The global rise in chronic diseases, such as vaginal and cervical cancer, has prompted an increase in the number of screening programmes.
While HPV (human papillomavirus) testing is used to screen for the presence of human papillomavirus in the cervix, which can lead to cervical cancer, the pap test (Papanicolaou test) is an effective screening measure for determining whether cervical cells are abnormal or normal. However, the pap test's low reliability and accuracy may pose a barrier to industry growth in the coming years.
In terms of test type, HPV and Pap Testing Market will gain market share due to rising consumer awareness and cervical cancer screening penetration. This testing procedure is self-collecting and can identify women who are at high risk for future cancer.
Read More @ https://cmiinfonest.blogspot.com/2023/01/the-global-hpv-and-pap-testing-market.html
